Higher 9.1 GBq Lutetium-177 PSMA Activity Leaves Tumor and Kidney Doses Unchanged
A retrospective single-center study of 76 prostate cancer patients found that raising the injected activity of Lu-PSMA-I&T from 7.4 to ...
A retrospective single-center study of 76 prostate cancer patients found that raising the injected activity of Lu-PSMA-I&T from 7.4 to ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.